The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development. The new Center will integrate AI with traditional drug discovery methods to identify and design new small-molecule therapeutics with unprecedented speed and precision. Unlike conventional drug discovery, which can take years and cost billions, AI-driven approaches enable researchers to rapidly navigate a vast chemical landscape, including natural products, to pinpoint promising drug candidates. By leveraging Mount Sinai’s world-leading expertise in machine learning, chemical biology, and biomedical data science, the Center aims to bring innovative treatments to patients faster—particularly for diseases with urgent unmet needs, including cancer, metabolic disorders, and neurodegenerative diseases.

The National Comprehensive Cancer Network (NCCN)—an alliance of leading cancer centers—celebrated 30 years of helping people with cancer to live better lives during the NCCN 2025 Annual Conference, March 28-30 in Orlando, Florida. The yearly event brings together leading minds and subject matter experts in front of a multidisciplinary audience to share the latest recommendations for cancer treatment and prevention.

Unchanged since 1996, Sweden's hexavalent chromium exposure limit is higher than in several other countries. A research study from Lund University in Sweden shows that even workers exposed to levels of chromium below the Swedish limit display significant cell changes long before cancer develops. A proposal from the Swedish Work Environment Authority to lower the limit has now been put forward.

A team of researchers developed a novel tool to help understand consumer behavior at the county level, and to study the relationship between where people shop for their food and the risk of obesity-related cancers. Their findings are published in BMC Medicine.

CNIO researchers discover that, in mice that eat a lot of fat, cancer cells travelling through the blood surround themselves with platelets, which act as an armor-like protection as they spread.

In addition, in animals with a fatty diet it is easier for tumor cells to 'nest' in other organs and give rise to metastasis of the primary tumor.

 “These results anticipate a future in which dietary changes, together with the control of platelet activity, will complement antitumor treatments,” says Héctor Peinado, of the Spanish National Cancer Research Center (CNIO).

The study is published in 'Nature Communications’.